ResMed Inc (RMD) stock
RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3012% below fair value
$239.53+0.64 (+0.27%)
Close on Nov 13, 2026Market cap $33.69BP/E 21.8Yield 1.00%
ResMed enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
ResMed's enterprise value was $33.20B on Nov 11, 2026, against $36.21B a year earlier. Over the last 5 years it ranged from $20.55B to $38.98B, with a median of $32.45B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $33.20B | -2.4% |
| 2025 | Dec 31, 2025 | $34.03B | +2.7% |
| 2024 | Dec 31, 2024 | $33.15B | +32.1% |
| 2023 | Dec 29, 2023 | $25.10B | -17.1% |
| 2022 | Dec 30, 2022 | $30.29B | -19.6% |
| 2021 | Dec 31, 2021 | $37.69B | +24.0% |
| 2020 | Dec 31, 2020 | $30.39B | +37.4% |
| 2019 | Dec 31, 2019 | $22.12B | +38.2% |
| 2018 | Dec 31, 2018 | $16.01B | +30.6% |
| 2017 | Dec 29, 2017 | $12.26B | +34.2% |
| 2016 | Dec 30, 2016 | $9.13B | +27.4% |
| 2015 | Dec 31, 2015 | $7.17B | -2.2% |
| 2014 | Dec 31, 2014 | $7.33B | +20.8% |
| 2013 | Dec 31, 2013 | $6.07B | +14.0% |
| 2012 | Dec 31, 2012 | $5.32B | +62.4% |
| 2011 | Dec 30, 2011 | $3.28B | -31.9% |
| 2010 | Dec 31, 2010 | $4.81B | +33.1% |
| 2009 | Dec 31, 2009 | $3.62B | – |
See a number that looks wrong?